XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2021   24,679,000        
Beginning balance at Dec. 31, 2021 $ 275,949 $ 247 $ (355,159) $ 314,094 $ (13,524) $ 330,291
Beginning balance (in shares) at Dec. 31, 2021     (11,861,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (2,910)         (2,910)
Currency translation adjustment 1,849       1,849  
Shares issued for employee benefit plan and compensation (in shares)   145,000        
Shares issued for employee benefit plan and compensation 324 $ 1   323    
Purchase of treasury shares (in shares)     (225,000)      
Purchase of treasury shares (7,354)   $ (7,354)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,499     2,499    
Ending balance (in shares) at Mar. 31, 2022   24,831,000        
Ending balance at Mar. 31, 2022 270,357 $ 248 $ (362,513) 316,916 (11,675) 327,381
Ending balance (in shares) at Mar. 31, 2022     (12,086,000)      
Beginning balance (in shares) at Dec. 31, 2021   24,679,000        
Beginning balance at Dec. 31, 2021 275,949 $ 247 $ (355,159) 314,094 (13,524) 330,291
Beginning balance (in shares) at Dec. 31, 2021     (11,861,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 78          
Currency translation adjustment $ (5,464)          
Purchase of treasury shares (in shares) (355,000)          
Purchase of treasury shares $ (11,211)          
Ending balance (in shares) at Jun. 30, 2022   24,862,000        
Ending balance at Jun. 30, 2022 265,114 $ 249 $ (366,370) 319,854 (18,988) 330,369
Ending balance (in shares) at Jun. 30, 2022     (12,216,000)      
Beginning balance (in shares) at Mar. 31, 2022   24,831,000        
Beginning balance at Mar. 31, 2022 270,357 $ 248 $ (362,513) 316,916 (11,675) 327,381
Beginning balance (in shares) at Mar. 31, 2022     (12,086,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss 2,988         2,988
Currency translation adjustment (7,313)       (7,313)  
Shares issued for employee benefit plan and compensation (in shares)   23,000        
Shares issued for employee benefit plan and compensation 302 $ 1   301    
Purchase of treasury shares (in shares)     (130,000)      
Purchase of treasury shares (3,857)   $ (3,857)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,637     2,637    
Ending balance (in shares) at Jun. 30, 2022   24,862,000        
Ending balance at Jun. 30, 2022 265,114 $ 249 $ (366,370) 319,854 (18,988) 330,369
Ending balance (in shares) at Jun. 30, 2022     (12,216,000)      
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 $ 268,406 $ 250 $ (368,194) 326,839 (21,187) 330,698
Beginning balance (in shares) at Dec. 31, 2022 (12,295,305)   (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (61,363)         (61,363)
Currency translation adjustment 1,916       1,916  
Shares issued for employee benefit plan and compensation (in shares)   189,000        
Shares issued for employee benefit plan and compensation 352 $ 2   350    
Purchase of treasury shares (in shares)     (53,000)      
Purchase of treasury shares (812)   $ (812)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,540     2,540    
Ending balance (in shares) at Mar. 31, 2023   25,197,000        
Ending balance at Mar. 31, 2023 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Ending balance (in shares) at Mar. 31, 2023     (12,348,000)      
Beginning balance (in shares) at Dec. 31, 2022   25,000,000        
Beginning balance at Dec. 31, 2022 $ 268,406 $ 250 $ (368,194) 326,839 (21,187) 330,698
Beginning balance (in shares) at Dec. 31, 2022 (12,295,305)   (12,295,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss $ (71,774)          
Currency translation adjustment $ (1,201)          
Purchase of treasury shares (in shares) (58,000)          
Purchase of treasury shares $ (855)          
Ending balance (in shares) at Jun. 30, 2023   25,254,000        
Ending balance at Jun. 30, 2023 $ 199,999 $ 253 $ (369,049) 332,259 (22,388) 258,924
Ending balance (in shares) at Jun. 30, 2023 (12,353,278)   (12,353,000)      
Beginning balance (in shares) at Mar. 31, 2023   25,197,000        
Beginning balance at Mar. 31, 2023 $ 211,039 $ 252 $ (369,006) 329,729 (19,271) 269,335
Beginning balance (in shares) at Mar. 31, 2023     (12,348,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (10,411)         (10,411)
Currency translation adjustment (3,117)       (3,117)  
Shares issued for employee benefit plan and compensation (in shares)   50,000        
Shares issued for employee benefit plan and compensation 373 $ 1   372    
Purchase of treasury shares (in shares)     (5,000)      
Purchase of treasury shares (43)   $ (43)      
Shares issued to directors (in shares)   7,000        
Shares issued to directors 0          
Employee and director stock-based compensation 2,158     2,158    
Ending balance (in shares) at Jun. 30, 2023   25,254,000        
Ending balance at Jun. 30, 2023 $ 199,999 $ 253 $ (369,049) $ 332,259 $ (22,388) $ 258,924
Ending balance (in shares) at Jun. 30, 2023 (12,353,278)   (12,353,000)